Another exciting MS related development is the approval of fampridine-sr, which has been found to improve impulse conduction in nerve fibers. Fampridine will be marketed starting in March under the name of Ampyra. See e.g.
"Oral MS Drug Fampridine is Trifecta of Firsts for People with MS, Says National MS Society":http://tinyurl.com/yhbszro